1
|
Ghazizadeh H, Khorasani MY, Shabani N, Sahranavard T, Zare-Feyzabadi R, Mohammadi-Bajgiran M, Timar A, Oladi MR, Moazedi S, Mosalman-Zadeh N, Khedmatgozar H, Rohban M, Hasanzadeh E, Javandoost A, Nazarpour S, Bahrami A, Ferns GA, Haghdoost AA, Esmaily H, Ghayour-Mobarhan M. Relationship between Clinical, Demographic and Socio-economic Factors with Suicide Ideation; A cross-sectional Study. Comb Chem High Throughput Screen 2021; 25:1047-1057. [PMID: 33653243 DOI: 10.2174/1386207324666210302094438] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2020] [Revised: 01/26/2021] [Accepted: 02/08/2021] [Indexed: 11/22/2022]
Abstract
BACKGROUND Suicide has grown in global prevalence as a public health problem. We aimed to evaluate the association of socioeconomic factors, biochemical and hematologic tests, and suicide ideation. METHODS In this cross-sectional study, 8267 Iranian adults aged 35 - 65 years old were enrolled. The assessment of suicide ideation was made by the completion of Beck's depression inventory (BDI) questionnaire; according to one specific item on the questionnaire: "have you ever decided to suicide in the past week?" RESULTS According to our results, 6.9 % of subjects had ideation of suicide. The results showed high levels of FBG, RBC, MCHC, and hs-CRP were associated with suicide ideation. Obese, single subjects, and current-smokers had a higher risk of suicide ideation. CONCLUSION Increased physical activity, obesity, and smoking are associated with a high risk of suicide ideation; whilst, a high MCHC is related to low risk of suicide ideation in Iranian adults.
Collapse
Affiliation(s)
- Hamideh Ghazizadeh
- Student Research Committee,Mashhad University of Medical Sciences, Mashhad. Iran
| | | | - Niloofar Shabani
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad. Iran
| | - Toktam Sahranavard
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad. Iran
| | - Reza Zare-Feyzabadi
- International UNESCO Center for Health-Related Basic Sciences and Human Nutrition,Mashhad University of Medical Sciences, Mashhad. Iran
| | - Maryam Mohammadi-Bajgiran
- International UNESCO Center for Health-Related Basic Sciences and Human Nutrition,Mashhad University of Medical Sciences, Mashhad. Iran
| | - Ameneh Timar
- International UNESCO Center for Health-Related Basic Sciences and Human Nutrition,Mashhad University of Medical Sciences, Mashhad. Iran
| | - Mohammad Reza Oladi
- International UNESCO Center for Health-Related Basic Sciences and Human Nutrition,Mashhad University of Medical Sciences, Mashhad. Iran
| | - Sara Moazedi
- Departmentof Nutrition Sciences, Varastegan Institute for Medical Sciences, Mashhad. Iran
| | - Negin Mosalman-Zadeh
- Departmentof Nutrition Sciences, Varastegan Institute for Medical Sciences, Mashhad. Iran
| | - Hamed Khedmatgozar
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad. Iran
| | - Mohadeseh Rohban
- International UNESCO Center for Health-Related Basic Sciences and Human Nutrition,Mashhad University of Medical Sciences, Mashhad. Iran
| | - Elahe Hasanzadeh
- International UNESCO Center for Health-Related Basic Sciences and Human Nutrition,Mashhad University of Medical Sciences, Mashhad. Iran
| | - Ali Javandoost
- International UNESCO Center for Health-Related Basic Sciences and Human Nutrition,Mashhad University of Medical Sciences, Mashhad. Iran
| | - Shahin Nazarpour
- International UNESCO Center for Health-Related Basic Sciences and Human Nutrition,Mashhad University of Medical Sciences, Mashhad. Iran
| | - Afsaneh Bahrami
- International UNESCO Center for Health-Related Basic Sciences and Human Nutrition,Mashhad University of Medical Sciences, Mashhad. Iran
| | - Gordon A Ferns
- Division of Medical Education, Brighton & Sussex Medical School, Falmer, Brighton, Sussex. United Kingdom
| | - Ali Akbar Haghdoost
- Modeling in Health Research Center, Kerman University of Medical Sciences, Kerman. Iran
| | - Habibollah Esmaily
- Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad. Iran
| | - Majid Ghayour-Mobarhan
- International UNESCO Center for Health-Related Basic Sciences and Human Nutrition,Mashhad University of Medical Sciences, Mashhad. Iran
| |
Collapse
|
2
|
Yaghooti-Khorasani M, Ghazizadeh H, Bijari M, Mohammadi-Bajgiran M, Oladi MR, Zare-Feizabadi R, Timar A, Nazarpour S, Khedmatgozar H, Rohban M, Hasanzadeh E, Javandoost A, Banpoor H, Sheikh Andalibi MS, Moazedi S, Mosalman-Zadeh N, Aghasizadeh M, Ferns GA, Esmaily H, Ghayour-Mobarhan M. Evaluation of ABO blood group in subjects with CVD risk factors in a population sample from northeastern Iran. Diabetes Metab Syndr 2020; 14:1689-1695. [PMID: 32905941 DOI: 10.1016/j.dsx.2020.08.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/10/2020] [Revised: 08/24/2020] [Accepted: 08/25/2020] [Indexed: 10/23/2022]
Abstract
BACKGROUND AND AIMS The ABO blood group system is a genetic polymorphism which can affect the clearance of von Willebrand factor. We aimed to assess the levels of newer biomarkers of cardiovascular disease (CVD) risk; pro-oxidant-antioxidant balance (PAB), high sensitivity C-reactive protein (hs-CRP) and anti-heat-shock protein27 (anti-Hsp27) antibody titers in subjects with various blood groups (A, B, AB and O) and with or without traditional CVD risk factors. METHODS The cross-sectional study comprised 6910 subjects. Antigen-antibody agglutination was evaluated by the slide test method for identification of ABO blood groups. RESULTS Among three markers, only Serum anti-Hsp27 titers significantly differed between the four blood groups and showed the highest and lowest values in AB and O blood groups (0.26 ± 0.22 and 0.23 ± 0.18 OD, respectively; P < 0.05). Serum anti-Hsp27 was higher in individuals with an AB blood group with metabolic syndrome (MetS), dyslipidemia, hypertension (HTN) and obesity and it was lower in subjects with O blood group; though, two other biomarkers, serum PAB and hs-CRP, were not significantly different between the ABO blood groups. However, they were not different among blood groups in participants with or without diabetes mellitus (DM) (P > 0.05). CONCLUSION Individuals with an AB blood group and high levels of anti-Hsp27 antibody titers may be predisposed to CVDs that can be mediated through the traditional CVD risk factors among middle-aged subjects from northeastern Iran. The fact that differences in anti Hsp27 are only found in the subgroup with other risk factors suggest that the difference between ABO blood groups is a consequence rather than a cause.
Collapse
Affiliation(s)
| | - Hamideh Ghazizadeh
- Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran; International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Moniba Bijari
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Maryam Mohammadi-Bajgiran
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mohammad Reza Oladi
- International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Reza Zare-Feizabadi
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Ameneh Timar
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Shahin Nazarpour
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Hamed Khedmatgozar
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Center for Biotechnology and Genomics, Texas Tech University, Lubbock, TX, USA
| | - Mohadeseh Rohban
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Elahe Hasanzadeh
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Faculty of Medicine, Mashhad University of Medical Science, Mashhad, Iran
| | - Ali Javandoost
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Hamed Banpoor
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | | | - Sara Moazedi
- Department of Nutrition Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran
| | - Negin Mosalman-Zadeh
- Department of Nutrition Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran
| | - Maliheh Aghasizadeh
- Student Research Committee, Department of Molecular Medicine, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran
| | - Gordon A Ferns
- Division of Medical Education, Brighton & Sussex Medical School, Falmer, Brighton, Sussex, UK
| | - Habibollah Esmaily
- Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
| | - Majid Ghayour-Mobarhan
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
| |
Collapse
|